DRKS00026004招募中未知
Prospective clinical investigation of the effects of bariatric surgery on nocturnal hypoxaemic burden in patients with severe obesity - BASH
Klinikum Saarbrücken0 个研究点目标入组 100 人开始时间: 2021年8月19日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- N/a: Single Arm Study
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 18 Years 至 65 Years（—）
- 性别
- All
入选标准
- •Indication for bariatric surgery according to the S3 guideline: Surgery of obesity and metabolic diseases
- •The patient is fully informed and agrees to participate in the study
- •The surgical indication has been secured by a multidisciplinary team consisting of a nutritionist, surgeon, psychosomatic specialist / psychologist and, if necessary a general doctor.
排除标准
- •Consent to participate in the study has not been given or will be revoked.
- •Bariatric surgery is not performed.
- •Previously known severe chronic respiratory failure requiring oxygen therapy
- •General inoperability
- •Contraindication to bariatric surgery according to the S3 guideline: Surgery for obesity and metabolic diseases:
- •- Unstable psychopathological conditions, untreated bulimia nervosa, active substance dependence
- •- Consuming underlying diseases, malignant neoplasms, untreated endocrine causes, chronic diseases worsened by a postoperative catabolic metabolism
- •- Present or planned pregnancy
研究者
相似试验
招募中
不适用
Clinical prospective study to investigate efficacy and safety of immune-cell therapy for malignant tumorsMalignant tumorJPRN-UMIN000004610Kanazawa university600
已完成
不适用
Clinical prospective study to investigate efficacy of NK cell therapy for malignant tumors.JPRN-UMIN000008046Seta Clinic Group20
已完成
不适用
Clinical prospective study to investigate efficacy of WT1 peptide (PepTivator(R))-pulsed dendritic cell vaccination therapyMalignant tumor (all HLA types)JPRN-UMIN000009447Seta Clinic Group5
进行中（未招募）
1 期
A Study of RoActemra/Actemra (tocilizumab) in Comparison to Enbrel (etanercept) in Patients With Rheumatoid Arthritis and Increased Risk for Heart Disease.MedDRA version: 14.0Level: PTClassification code 10039073Term: Rheumatoid arthritisSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disordersRheumatoid ArthritisEUCTR2010-020065-24-ESF. Hoffmann-La Roche Ltd.2,800
进行中（未招募）
1 期
A Study of RoActemra/Actemra (tocilizumab) in Comparison to Enbrel (etanercept) in Patients With Rheumatoid Arthritis and Increased Risk for Heart Disease.MedDRA version: 16.1Level: PTClassification code 10039073Term: Rheumatoid arthritisSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disordersRheumatoid ArthritisEUCTR2010-020065-24-BEF. Hoffmann-La Roche Ltd.3,080